Drug Action
Procarbazine is a mild monoamine-oxidase inhibitor.
PDF page 1011
Drug reference
Procarbazine is a mild monoamine-oxidase inhibitor.
PDF page 1011
Hodgkin’s lymphoma ▶BY MOUTH ▶Adult: (consult local protocol)
PDF page 1011
Pre-existing severe leucopenia. pre-existing severe thrombocytopenia
PDF page 1011
Cardiovascular disease. cerebrovascular disease . epilepsy. phaeochromocytoma. procarbazine is a mild monoamineoxidase inhibitor (dietary restriction is rarely considered necessary)
PDF page 1011
RISKS OF INCORRECT DOSING OF ORAL ANTI-CANCER MEDICINES See Cytotoxic drugs p. 938.
PDF page 1011
→Appendix 1: procarbazine
PDF page 1011
▶Common or very common Appetite decreased ▶Frequency not known Azoospermia. hepatic disorders. infection. lethargy. leucopenia. nausea. neutropenia. ovarian failure. pneumonitis. skin reactions. thrombocytopenia. vomiting
PDF page 1011
Contraceptive advice required, see Pregnancy and reproductive function in Cytotoxic drugs p. 938.
PDF page 1011
Avoid (teratogenic in animal studies and isolated reports in humans). See also Pregnancy and reproductive function in Cytotoxic drugs p. 938.
PDF page 1011
Discontinue breast-feeding.
PDF page 1011
Manufacturer advises caution in mild to moderate impairment; avoid in severe impairment.
PDF page 1011
Caution in mild to moderate Immune system and malignant disease impairment. Avoid in severe impairment.
PDF page 1011
There can be variation in the licensing of different medicines containing the same drug. Capsule CAUTIONARY AND ADVISORY LABELS 4 ▶Procarbazine (Non-proprietary) Procarbazine (as Procarbazine hydrochloride) 50 mg Procarbazine 50mg capsules | 50 capsule P £411.35– £479.63 DT = £445.49
PDF page 1011
(consult local protocol)
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1011